Clinical Trials

Current Clinical Trials

AST001: A double-blind, randomized, placebo-controlled multicenter study to assess the safety and efficacy of AST-120 in mild to moderately active Crohn's patients with fistulas.

For detailed information please go to: www.clinicaltrials.gov

AST013: Safety and efficacy of AST-120 in patients with GERD who continue to be symtomatic on a standard dose of PPI

For detailed information please go to: www.clinicaltrials.gov

AST014: Safety and efficacy of AST-120 in patients with non-constipating Irritable Bowel Syndrome (being conducted in Belgium)

For detailed information please go to: www.clinicaltrials.gov

AST015:  Safety and efficacy of AST-120 compared to lactulose in patients with hepatic encephalopathy

For detailed information please go to: www.clinicaltrials.gov

Ocera is committed to providing information to patients and health care providers on ongoing trials and communicate the results of these trials in a timely manner.